1. Кукушкин М.Л., Хитров Н.К. Общая патология боли. М., 2004
2. Cohen HW, Gibson G, Alderman M.H. Excess risk of myocardial infarction
in patients treated with antidepressant medication. Association with use of
tricyclic agents. Am J Med 2000 108 P2–8.
3. McLean MJ, Morell MJ, Willmore LJ et al. Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study Epilepsia 1999 Vol.40 965–72.
4. Bakonja M. Gabapentin monotherapy for the symptomatic treatment of
painful neuropathy: a multicenter, double-blind, placebo-controlled trial in
patients with diabetes mellitus. Epilepsia – 1999 – Vol.40 (Suppl.6) –
P.57–59.
5. Attal N, Cruccu G, Haanpaa M et al. EFNS guidelines on pharmacological
treatment of neuropathic pain Euro Neurology 2006 13 1153–69.
6. Rosenstock J, Tuchman M, LaMoreaux L et al. Pregabalin for the treatment
of painful diabetic peripheral neuropathy/ A double-blind placebo-controlled
trial. Pain 2004; 110 –628–38.
7. Sabatowski R, Galevz R, Cherry DA et al. Pregabalin redused pain and
improves sleep and mood disturbances in patients with post-herpetic neuralgia.
Results of a randomized, placebo-controlled clinical trial. Pain 2004;
109: 26–35.
8. Данилов А.Б., Давыдов О.С. Нейропатическая боль. М.: Изд-во Боргес,
2007: 32–55.
9. Stacey BR, Dworkin RH, Murphy K et al. Pregabalin in the treatment of
refractory neuropathic pain: results of a 15-month open-label trial. Pain
Med. 2008 Mar 11.
10. Jann MW, Slade J.H. Antidepressant agents for the treatment of chronic
pain and depression. Pharmacotherapy 2007; 27: 1571–87.
11. Методические рекомендации по диагностике и лечению невропа-
тической боли. Под ред. акад. РАМН Н.Н. Яхно. М.: Изд РАМН, 2008.
12. Abstracts of the Second International Congress on Neuropathic Pain
(NeuPSIG). June 7–10, 2007, Berlin, Germany. Eur J Pain – 2007; 11
(Suppl): S1–S209.
13. Breivic H, Collett B, Ventafridda V et al. Survey of chronic pain in Europe:
prevalence, impact on daily life, and treatment Euro J Pain. 2006 ; 287–33.
14. Torrance N, Smith B, Bennett M. et al. The epidemiology of chronic pain of
predominantly neuropathic origin. Results from a general population survey.
J Pain 2006; 17281–9.
15. Neuropathic Pain: Pathophysiology and Treatment Progress in pain
research and management, ed. PT Hansson, HL Fields, RG Hill, P Marchettini,
IASP Press, Seattle. 2001; 21.
16. Bouhassira D, Attal N, Alchaar H et al. Comparison of pain syndromes
associated with nervous or somatic lesions and development of a new neuropathic
pain diagnostic questionnaire (DN4). Pain 2005; 114 – 29–6.
17. Яхно Н.Н., Кукушкин М.Л., Давыдов О.С. и др. Результаты Российско-
го эпидемиологического исследования распространенности невропа-
тической боли, ее причин и характеристик в популяции амбулатор-
ных больных, обратившихся к врачу-неврологу. Боль 2008;–3: 24–32.
18. Montero HJ, Guttierez-Rivas E, Fernandez J et al. Epidemiological study of
prevalence incidence and neuropathic pain characterization in neurology
unit. PREVADOL study Neurologia 2005; 20: 385–9.
19. Kingery W.S. A critical review of controlled clinical trials for peripheral
neuropathic pain and complex regional pain syndromes. Pain 1997; 73 123–39.
20. Siddall PJ, Cousins MJ, Otte A et al. Pregabalin in central neuropathic pain
associated with spinal cord injury: a placebo-controlled trial. Neurology
2006; Vol.67: 1792–000.